Current News from our Company

Maik Lander becomes sole CEO of Virion\Serion GmbH

Dear Sir or Madam,

We are pleased to announce that Maik Lander has assumed sole management of the company with immediate effect.

Maik Lander, who holds a degree in biotechnology and chemical engineering, brings more than fifteen years of experience...

\ read more

Maik Lander übernimmt alleinige Geschäftsführung der Virion\Serion GmbH

Sehr geehrte Damen und Herren, 

hiermit geben wir bekannt, dass Maik Lander ab sofort die alleinige Geschäftsführung des Unternehmens übernommen hat.

Maik Lander verfügt als Diplom-Ingenieur für Biotechnologie und Chemietechnik über mehr als...

\ read more

Executive management change

Dear Sir or Madam,

Effective February 1, 2026, there will be a change in the management of our company.

Mr. Christian Naegel, who has been successfully working as Chief Operating Officer (COO) in our company for many years, will be appointed to the...

\ read more

Pioneering Compliance with New Industry Standards

Institut Virion\Serion GmbH Achieves IVDR Certification for Class B Products

\ read more

IVDR certificate class C

The IVDR certificate for our class C products with identifier HX 1098896-1 and effective date 2024-05-16

\ read more

Tropical Diseases on the Rise

Spread of the African West Nile virus in Germany

\ read more

Fight Sepsis!

© Fraunhofer ILT, Aachen / Volker Lannert

Virion\Serion receives research funding by the German Federal Ministry of Education and Research (BMBF)

 

\ read more